Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. ...
The success of therapeutic cancer vaccines hinges on overcoming the immunosuppressive tumor microenvironment (TME) and ...
Durable survival with TRIDENT in treatment-naïve advanced NSCLC In our prospective phase I clinical trial ...
Citraconate preserves stemness, mitigates ferroptosis, and potentiates T cell antitumor immunity by modulating the PDE1-cAMP-ALOX5 ...
Baulu E, Gardet C, Chuvin N, Depil S. TCR-engineered T cell therapy in solid tumors: ...
Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained ...
Xue G, Li X, Kalim M, Fang J, Jiang Z, Zheng N, et al. Clinical ...
Reck, M., Remon, J. & Hellmann, M. D. First-line immunotherapy for non-small-cell lung cancer. J. ...
Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell ...
Cell lines For macrophages, the RAW 264.7 cell line was purchased from Shanghai Yu Chun ...